Abstract
This article reviews the advances in neurosurgery, neuroradiology, and neuroendocrinology that have altered the management of patients with pituitary adenomas. These benign tumors can produce significant morbidity including loss of vision. Morbidity may be avoided or corrected if available diagnostic and therapeutic options are instituted appropriately.
MeSH terms
-
Adenoma / diagnostic imaging
-
Adenoma / drug therapy*
-
Adenoma / surgery
-
Animals
-
Bromocriptine / therapeutic use*
-
Combined Modality Therapy
-
Female
-
Humans
-
Male
-
Microsurgery
-
Pituitary Neoplasms / diagnostic imaging
-
Pituitary Neoplasms / drug therapy*
-
Pituitary Neoplasms / metabolism
-
Pituitary Neoplasms / surgery
-
Prolactin / metabolism*
-
Rats
-
Sphenoid Sinus / surgery
-
Tomography, X-Ray Computed